AI Article Synopsis
- Telemedicine has been acknowledged as an important aspect of healthcare since 2010, but significant national trials only started in 2016 to create a legal framework for its integration.
- These trials, which concluded in December 2021, successfully involved over 100,000 patients, primarily those with heart conditions.
- The COVID-19 pandemic highlighted the effectiveness of remote healthcare practices like teleconsultation and telemonitoring, prompting the need for ongoing organizational and technical advancements to integrate telemedicine into everyday healthcare.
Article Abstract
Telemedicine has been recognized since 2010 as a constitutive element of care, however, it was not until 2016 that the first national experiments were able to be launched with the aim of validating a framework allowing a possible rapid passage in the common right. These experiments, which are due to end in December 2021, have succeeded in involving more than 100,000 patients, mainly suffering from cardiac pathologies. The arrival of COVID-19 has made it possible to measure the usefulness of practices at a distance both from teleconsultation and telemonitoring, with the appearance of organizational and technical innovations that must now be maintained and developed in order to integrate the telemedicine of tomorrow into our actual medicine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ancard.2021.09.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!